Market Tracker

02/28 7:33am ET

Myriad Genetics Inc (NASDAQ:MYGN)

19.25
Delayed Data
As of Feb 27
 +0.27 / +1.42%
Today’s Change
15.15
Today|||52-Week Range
39.74
+15.48%
Year-to-Date
Bullish and Bearish Reversals in the Market
Feb 27 / TheStreet.com - Paid Partner Content
Here's Why Invitae Stock Jumped as Much as 16.3% This Morning
Feb 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close18.98
Today’s open19.21
Day’s range18.69 - 19.30
Volume1,606,453
Average volume (3 months)1,556,408
Market cap$1.3B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-38.83%
Earnings growth (next 5 years)-4.30%
Revenue growth (last year)+4.25%
P/E ratio22.4
Price/Sales2.98
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.30+0.81%
QDELQuidel Corp+0.74+3.50%
--Quidel Corp-0.20-1.01%
ALRPRBAlere Inc-0.02-0.01%
Data as of 02/27/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts